Finstar Financial Group reinforces senior Fintech team
Finstar Financial Group (“Finstar”) announces further senior appointments to its management team with the recruitment of Eugene Timko as Investment Director, Michele Tucci as Head of Mobile Products and Business Development, and Alexander Ivanov who has been appointed to develop venture capital investments. These latest appointments reflect Finstar’s strategy to continue with the successful expansion of its fintech and financial services investment program.
As the global economy moves into a truly digital era, investment in the fintech sector continues to gather pace and overall fintech investment reached $5.7 billion during the first quarter of 2016. Finstar Financial Group is focusing its efforts to capitalize on the many exciting opportunities present in the space by seeking out the brightest companies that are ready to challenge the status quo in the financial services industry.
Nicholas Jordan, CEO of Finstar, commented: “Finstar has both the resources, expertise, technologies and geographic reach to develop ground-breaking solutions to rapidly changing corporate and consumer needs in the financial services industry. Finstar’s decision to strengthen its focus on fintech solutions across a number of sub-sectors reflects the manner in which fintech investments are bucking trends across the globe. We see tremendous long-term growth opportunities across all industry segments, from lending platforms to insurance and asset management.
Our latest senior management appointments are of the highest caliber and reflect our ambition to seek out the best talent in the industry and deploy our Human and Financial capital to develop the most innovative credit products and solutions. Finstar is building a formidable team and a knowledge-sharing technological platform across multiple geographies.”
Eugene Timko will be responsible for evaluating venture capital investment opportunities in the fintech and services industry with a particular focus on disruptive business models and technology. Eugene has been focused on the fintech industry since 2012, when he successfully completed the acquisition of a mobile banking business by Inventure Partners, a VC fund specialized on disruptive technology businesses. His most recent transactions include the acquisition of a 50% stake in Hearst Independent Media Publishing B.V., a former subsidiary of Sanoma Oyj, publisher of luxury magazines and a successful investment in car service Gett and the Busfor budget bus company. Prior to joining Inventure Partners, Eugene served as the IBD Associate of Morgan Stanley and participated in various M&A and ECM transactions in technology, media and telecom industry.
In his new role, Michele Tucci will grow mobile products and partnerships that will contribute to the Group’s FinTech global expansion plans. Michele has more than 16 years of international industry and consulting experience across Asia Pacific, USA, Europe, Middle East and Africa. He has held senior management positions including Director of International Business Development at Mint Payments, a listed mobile and online payment and transaction processing company, and Vice President and Senior Managing Consultant of the professional services arm of MasterCard Worldwide.
Alexander Ivanov will be responsible for developing venture capital activities in fintech. Alexander has experience in venture capital, financial services, and technology. Previously, he was a co-founder of ‘Life.SREDA’, a venture capital firm focusing on investments in fintech mobile and Internet projects in the U.S., Western and Eastern Europe. He has held senior positions in international financial groups, including Head of Balanced Scorecard division at BCS Financial Group, a leading financial service group that provides innovative and customizable high and low touch trading solutions for global and emerging markets. His practical expertise is enhanced by his study of executive PE and VC courses at the London Business School and Harvard Business School.
Finstar Financial Group is an international private equity group. Founded in 1996, the Group has significant experience in launching start-up projects and in restructuring and expanding of companies in selected industries. Finstar operates in financial markets, the IT and telecoms field, perfumery-cosmetic retailing and in commercial and trade real estate. The Group has under its management assets worth a total of more than $2 billion. Over the years Finstar has developed substantial operational experience which helps to implement a value-adding strategy, introducing high international standards of corporate governance, innovation, marketing and building competitive advantages, all of which are vital to create value in the long-term.
Read more about Finstar: www.finstar.com
Finstar Financial Group
Tel: +7 905 529 12 52
Tel: +44 20 7866 7887
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage22.2.2018 06:00 | Pressemelding
Ferring Pharmaceuticals and MSD, known as Merck & Co., Inc., Kenilworth, N.J., U.S.A., through its MSD for Mothers initiative, today announced the completion of CHAMPION (Carbetocin Haemorrhage Prevention), a global clinical trial conducted by the Human Reproduction Program (HRP) at the World Health Organization (WHO). CHAMPION is investigating whether Ferring’s proprietary and heat-stable carbetocin could offer a new solution to prevent excessive bleeding after childbirth (postpartum haemorrhage or PPH).2,3 Involving nearly 30,000 women in 10 countries, it is the largest clinical trial ever conducted in PPH.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221006496/en/ Each year, 14 million mothers are affected by PPH.4 As the leading direct cause of maternal mortality, 480,000 mothers died from PPH between 2003-09.1 Even when women survive, PPH can result in the need for serious medical interventions, including surgica
The Nippon Foundation: Project to Map Ocean Floor by 2030 Now Operational22.2.2018 05:00 | Pressemelding
The Nippon Foundation Chairman Yohei Sasakawa announced at a press conference today that The Nippon Foundation – GEBCO Seabed 2030 Project is now operational. The Project will realize Mr. Sasakawa’s vision of mapping the entire ocean floor by 2030. The Nippon Foundation has pledged US$2 million annually, and is calling for additional support from the global ocean community. Mr. Sasakawa noted, “The Nippon Foundation alone cannot achieve the objectives of this ambitious project. We will need the support of diverse stakeholders, including maritime corporations and technical experts. It is crucial that the ocean community comes together to achieve this goal”. He was joined by leading ocean-mapping experts, who emphasized that understanding the bathymetry of the global ocean is imperative for improving maritime navigation, and also for enhancing our ability to predict climate change and monitor marine biodiversity and resources. A comprehensive map of the seafloor will assist global effort
Vertex Initiates First Phase 3 Study of VX-659, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis21.2.2018 21:01 | Pressemelding
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it is initiating the first Phase 3 study of VX-659, tezacaftor and ivacaftor as an investigational triple combination regimen for people with cystic fibrosis (CF) who have one F508del mutation and one minimal function mutation. The study will enroll 360 patients, and the primary endpoint of the study is the mean absolute change from baseline in percent predicted forced expiratory volume in one second (ppFEV1) at week four of treatment. The study is designed to support the submission of a New Drug Application (NDA) in the U.S. using data from the 4-week primary efficacy endpoint together with safety data through 12 weeks of treatment. “Our goal is to bring the best triple combination to patients as rapidly as possible, and this first Phase 3 study of VX-659 in combination with tezacaftor and ivacaftor is a significant step toward that goal,” said Jeffrey Chodakewitz, M.D., Executive Vice President and Chief Medical
Universal Laser Systems® Expands Portfolio of Laser Material Processing Systems with the ULTRA Platform Series21.2.2018 18:00 | Pressemelding
ULTRA platform-based laser systems are designed and ideally suited for precision laser cutting, laser ablation, and laser surface modification in manufacturing, research and development, academic research and prototyping environments. Major features of the series include rapid, high-accuracy laser beam positioning, and the flexibility to be configured with 9.3 and 10.6 µm CO2 lasers and 1.06 µm fiber lasers. All lasers are air-cooled in a range of power from 10 to 150 watts for CO2 and 40 to 50 watts for fiber lasers. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221005364/en/ The ULTRA 9MW offers MultiWave processing of thin materials. (Photo: Business Wire) The variety of wavelengths and power ranges make the ULTRA platforms highly effective in the areas of organic material modification, including plastic films, industrial fabrics, engineering plastics, laminating adhesives, composite materials, and many others utilized
Luxoft One of Six Companies Collaborating with Amazon Web Services to Accelerate Blockchain Adoption21.2.2018 16:30 | Pressemelding
Luxoft Holding Inc (NYSE:LXFT), a global IT service provider, announces today that it is collaborating with Amazon Web Services (AWS) to enable corporates to adopt blockchain and Distributed Ledger Technologies (DLT). Luxoft is one of six IT and consulting services companies to make its blockchain advisory and development services available to AWS users. “We are very excited to be working with AWS to help users engage with blockchain and DLTs,” said Vasiliy Suvorov, Vice President of Technology Strategy at Luxoft. “Blockchain is about removing data silos, improving trust and operational efficiencies. By using AWS to deploy and integrate DLTs into day-to-day processes, businesses can revolutionize how they operate.” Luxoft helps accelerate the deployment and integration of blockchain and DLT-based projects on AWS and is already working on a number of DLT projects using the cloud. For example, Luxoft is building a healthcare claims processing system for a leading healthcare provider usin
Westinghouse Electric Company to Provide Engineering Support at Vandellós 1 in Partnership with EDF21.2.2018 16:30 | Pressemelding
Westinghouse Electric Company and Electricité de France (EDF), in partnership, announced today that they have been awarded a contract from Empresa Nacional de Residuos Radiactivos (ENRESA), the Spanish agency responsible for radioactive waste management and nuclear plant decommissioning. The agreement covers a four-year engineering support contract for the latency phase of the dismantling and decommissioning project at Vandellós I Nuclear Power Station in Spain and includes the preparation of technical and licensing documentation. “We are extremely pleased that ENRESA has selected Westinghouse and EDF to continue supporting the decommissioning activities at Vandellós I Nuclear Power Station,” said Yves Brachet, Westinghouse vice president, Global Decommissioning, Decontamination, Remediation and Waste Management. “This contract further demonstrates Westinghouse’s global capabilities and expertise in providing innovative decommissioning solutions.” Sylvain Granger, head of EDF's decommi